Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection

被引:26
作者
Blackard, JT
Komurian-Pradel, F
Perret, M
Sodoyer, M
Smeaton, L
St Clair, JB
Chapman, S
Taylor, LE
Paranhos-Baccalà, G
Chung, RT
机构
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[2] CNRS BioMetrieux, UMR2714, IFR 128 BioSci Lyon Gerland, Lyon, France
[3] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA
[4] Miriam Hosp, Providence, RI 02906 USA
[5] Brown Univ, Sch Med, Dept Med, Providence, RI 02912 USA
关键词
hepatitis C virus; human immunodeficiency virus; co-infection; liver; antiretroviral therapy;
D O I
10.1002/jmv.20528
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV co-infection is associated with reduced HCV treatment response rates and accelerated HCV-related liver disease. Cytokines play an important role in regulating hepatic inflammation and fibrogenesis during chronic HCV infection, yet the roles of HIV and/or its therapies on cytokine expression are unknown. Total RNA was extracted from liver biopsies of 12 HCV monoinfected and 14 HCV/HIV co-infected persons. We used real-time PCR to quantify cytokines that contribute to innate and adaptive immune responses, including IFN alpha., IFN gamma, TNF alpha, TGF beta(1), IL-2, IL-4, IL-8, IL-10, and IL-12p40. Positive- and negative-strand HCV RNA levels were quantified using a molecular beacon approach. Detection of positive-strand HCV RNA was 100% in both groups; negative-strand HCV RNA was detected in four (33%) HCV mono-infected persons and in nine (64%) HCV/HIV co-infected persons. Median strand-specific HCV RNA levels were not significantly different between the two groups. Detection rates of cytokine mRNAs were lower for the HCV/HIV co-infected group compared to the HCV mono-infected group; the detection rates for TNF alpha, IL-8, and IL-10 were statistically significant. Overall, cytokine mRNA quantities were lower for HCV/HIV co-infected compared to HCV monoinfected persons, with the exception of TGF beta(1). These data suggest that a defect in cytokine activation may occur in HCV/HIV co-infected persons that limits efficient clearance of HCV from the liver.
引用
收藏
页码:202 / 207
页数:6
相关论文
共 36 条
[1]   Intra-hepatic messenger RNA levels for interferons and related genes in hepatitis C virus/HIV co-infected patients [J].
Abbate, I ;
Cappiello, G ;
Rosati, S ;
Tocci, G ;
Antonucci, G ;
Solmone, M ;
Longo, R ;
Spanò, A ;
Capobianchi, MR .
AIDS, 2004, 18 (04) :691-692
[2]   Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients [J].
Abbate, I ;
Romano, M ;
Longo, R ;
Cappiello, G ;
Lo Iacono, O ;
Di Marco, V ;
Paparella, C ;
Spano, A ;
Capobianchi, MR .
JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (04) :581-587
[3]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[4]   Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection [J].
Anthony, DD ;
Yonkers, NL ;
Post, AB ;
Asaad, R ;
Heinzel, FP ;
Lederman, MM ;
Lehmann, PV ;
Valdez, H .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4907-4916
[5]   Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy [J].
Benhamou, Y ;
Di Martino, V ;
Bochet, M ;
Colombet, G ;
Thibault, V ;
Liou, A ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 2001, 34 (02) :283-287
[6]   Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection [J].
Bica, I ;
McGovern, B ;
Dhar, R ;
Stone, D ;
McGowan, K ;
Scheib, R ;
Snydman, DR .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :492-497
[7]   Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome [J].
Breen, EC .
PHARMACOLOGY & THERAPEUTICS, 2002, 95 (03) :295-304
[8]  
Brown PMJ, 2001, CLIN BIOCHEM, V34, P167, DOI 10.1016/S0009-9120(01)00210-7
[9]   Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons [J].
Chung, RT ;
Andersen, J ;
Volberding, P ;
Robbins, GK ;
Liu, T ;
Sherman, KE ;
Peters, MG ;
Koziel, MJ ;
Bhan, AK ;
Alston, B ;
Colquhoun, D ;
Nevin, T ;
Harb, G ;
van der Horst, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :451-459
[10]   Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C [J].
Darby, SC ;
Ewart, DW ;
Giangrande, PLF ;
Spooner, RJD ;
Rizza, CR ;
Dusheiko, GM ;
Lee, CA ;
Ludlam, CA ;
Preston, FE .
LANCET, 1997, 350 (9089) :1425-1431